BlueRock Therapeutics Company
It is a regenerative medicine company.
Industry:
Regenerative Medicine
Investors Number:
3
Technology:
Regenerative Medicine
Last Funding Type:
Series B
Headquarters:
Canada
Founded Date:
2016-01-01
Investor Type:
For Profit
Funding Status:
M&A
Total Funding:
$34.5M
Estimated Revenue:
$1M to $10M
Employee Number:
101-250